Therapeutic Asset Ratings
158 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Trastuzumab Emtansine
Synchronous Bilateral Breast Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(60)
Tucatinib
Synchronous Bilateral Breast Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(60)
Vorasidenib
Astrocytoma, IDH-Mutant, Grade 3
Alliance for Clinical Trials in Oncology
P3
B
(60)
Avelumab
Urothelial Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(58)
Carboplatin
Prostate Cancer
Alliance for Clinical Trials in Oncology
P3
B
(58)
Rucaparib
Prostate Adenocarcinoma
Alliance for Clinical Trials in Oncology
P3
B
(58)
Azacitidine
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Alliance for Clinical Trials in Oncology
P2
B
(58)
gsk1120212
Uveal Melanoma
Alliance for Clinical Trials in Oncology
P2
B
(58)
Monomethyl Fumarate
Recurrent Glioblastoma
Alliance for Clinical Trials in Oncology
P2/3
B
(58)
Avelumab
Bladder Transitional Cell Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(57)
Avelumab
Renal Pelvis Urothelial Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(57)
Avelumab
Ureter Transitional Cell Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(57)
Avelumab
Urethra Transitional Cell Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(57)
Denosumab
Breast-Ovarian Cancer, Familial, Susceptibility To, 1
Alliance for Clinical Trials in Oncology
P3
B
(57)
Denosumab
Breast Disorder
Alliance for Clinical Trials in Oncology
P3
B
(57)
Denosumab
Breast Neoplasm
Alliance for Clinical Trials in Oncology
P3
B
(57)
Isosulfan blue
Breast Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(57)
MEGESTROL ACETATE IMPURITY B
Advanced Malignant Solid Neoplasm
Alliance for Clinical Trials in Oncology
P3
B
(57)
Capecitabine
Pancreatic Endocrine Carcinoma
Alliance for Clinical Trials in Oncology
P2
B
(57)
Eloxatin
Recurrent Islet Cell Carcinoma
Alliance for Clinical Trials in Oncology
P2
B
(57)
gsk1120212
Metastatic Uveal Melanoma
Alliance for Clinical Trials in Oncology
P2
B
(57)
Oxodotreotide
Pancreatic Endocrine Carcinoma
Alliance for Clinical Trials in Oncology
P2
B
(57)
Oxybutynin
Prostate Carcinoma
Alliance for Clinical Trials in Oncology
P2
B
(57)
CIS-DIAMMINEDICHLOROPLATINUM II
Pancreatic Acinar Cell Carcinoma
Alliance for Clinical Trials in Oncology
P2/3
B
(57)
CIS-DIAMMINEDICHLOROPLATINUM II
Pancreatic Adenosquamous Carcinoma
Alliance for Clinical Trials in Oncology
P2/3
B
(57)
Showing 76 to 100 of 158 assets
Previous
Page 4 of 7
Next